nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—Rilpivirine—Pazopanib—kidney cancer	0.564	1	CrCrCtD
Etravirine—ABCB1—kidney cancer	0.114	1	CbGaD
Etravirine—ABCB1—Temsirolimus—kidney cancer	0.0237	0.11	CbGbCtD
Etravirine—CYP3A4—Everolimus—kidney cancer	0.021	0.0977	CbGbCtD
Etravirine—CYP3A4—Temsirolimus—kidney cancer	0.0142	0.066	CbGbCtD
Etravirine—CYP2C9—Capecitabine—kidney cancer	0.0134	0.0622	CbGbCtD
Etravirine—ABCB1—Pazopanib—kidney cancer	0.0124	0.0579	CbGbCtD
Etravirine—ABCB1—Dactinomycin—kidney cancer	0.0114	0.0529	CbGbCtD
Etravirine—ABCB1—Gemcitabine—kidney cancer	0.00899	0.0418	CbGbCtD
Etravirine—CYP2C19—Sorafenib—kidney cancer	0.00894	0.0416	CbGbCtD
Etravirine—ABCB1—Erlotinib—kidney cancer	0.00887	0.0413	CbGbCtD
Etravirine—CYP2C9—Paclitaxel—kidney cancer	0.00837	0.039	CbGbCtD
Etravirine—ABCB1—Paclitaxel—kidney cancer	0.00812	0.0378	CbGbCtD
Etravirine—CYP3A4—Pazopanib—kidney cancer	0.00745	0.0347	CbGbCtD
Etravirine—CYP2C9—Sorafenib—kidney cancer	0.00743	0.0346	CbGbCtD
Etravirine—ABCB1—Sorafenib—kidney cancer	0.00721	0.0336	CbGbCtD
Etravirine—ABCB1—Vinblastine—kidney cancer	0.00712	0.0332	CbGbCtD
Etravirine—ABCB1—Vincristine—kidney cancer	0.007	0.0326	CbGbCtD
Etravirine—ABCB1—Sunitinib—kidney cancer	0.00584	0.0272	CbGbCtD
Etravirine—CYP3A4—Erlotinib—kidney cancer	0.00532	0.0247	CbGbCtD
Etravirine—CYP3A4—Paclitaxel—kidney cancer	0.00487	0.0226	CbGbCtD
Etravirine—ABCB1—Doxorubicin—kidney cancer	0.00438	0.0204	CbGbCtD
Etravirine—CYP3A4—Sorafenib—kidney cancer	0.00432	0.0201	CbGbCtD
Etravirine—CYP3A4—Vinblastine—kidney cancer	0.00427	0.0199	CbGbCtD
Etravirine—CYP3A4—Vincristine—kidney cancer	0.0042	0.0195	CbGbCtD
Etravirine—CYP3A4—Sunitinib—kidney cancer	0.0035	0.0163	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—kidney cancer	0.00262	0.0122	CbGbCtD
Etravirine—Rilpivirine—ABCB1—kidney cancer	0.000349	1	CrCbGaD
Etravirine—Hyperhidrosis—Gemcitabine—kidney cancer	6.36e-05	0.000651	CcSEcCtD
Etravirine—Gastrointestinal pain—Dactinomycin—kidney cancer	6.35e-05	0.00065	CcSEcCtD
Etravirine—Hypoaesthesia—Capecitabine—kidney cancer	6.33e-05	0.000648	CcSEcCtD
Etravirine—Tremor—Paclitaxel—kidney cancer	6.33e-05	0.000647	CcSEcCtD
Etravirine—Urinary tract disorder—Capecitabine—kidney cancer	6.29e-05	0.000643	CcSEcCtD
Etravirine—Hypersensitivity—Sorafenib—kidney cancer	6.28e-05	0.000643	CcSEcCtD
Etravirine—Insomnia—Vincristine—kidney cancer	6.28e-05	0.000642	CcSEcCtD
Etravirine—Anorexia—Gemcitabine—kidney cancer	6.27e-05	0.000642	CcSEcCtD
Etravirine—Vomiting—Vinblastine—kidney cancer	6.27e-05	0.000641	CcSEcCtD
Etravirine—Dizziness—Erlotinib—kidney cancer	6.27e-05	0.000641	CcSEcCtD
Etravirine—Ill-defined disorder—Paclitaxel—kidney cancer	6.27e-05	0.000641	CcSEcCtD
Etravirine—Connective tissue disorder—Capecitabine—kidney cancer	6.26e-05	0.00064	CcSEcCtD
Etravirine—Vomiting—Everolimus—kidney cancer	6.24e-05	0.000639	CcSEcCtD
Etravirine—Anaemia—Paclitaxel—kidney cancer	6.24e-05	0.000639	CcSEcCtD
Etravirine—Urethral disorder—Capecitabine—kidney cancer	6.24e-05	0.000639	CcSEcCtD
Etravirine—Paraesthesia—Vincristine—kidney cancer	6.23e-05	0.000638	CcSEcCtD
Etravirine—Dermatitis bullous—Doxorubicin—kidney cancer	6.21e-05	0.000635	CcSEcCtD
Etravirine—Rash—Everolimus—kidney cancer	6.19e-05	0.000634	CcSEcCtD
Etravirine—Dermatitis—Everolimus—kidney cancer	6.19e-05	0.000633	CcSEcCtD
Etravirine—Headache—Vinblastine—kidney cancer	6.18e-05	0.000632	CcSEcCtD
Etravirine—Angioedema—Paclitaxel—kidney cancer	6.17e-05	0.000631	CcSEcCtD
Etravirine—Headache—Everolimus—kidney cancer	6.15e-05	0.00063	CcSEcCtD
Etravirine—Abdominal pain—Dactinomycin—kidney cancer	6.14e-05	0.000628	CcSEcCtD
Etravirine—Body temperature increased—Dactinomycin—kidney cancer	6.14e-05	0.000628	CcSEcCtD
Etravirine—Asthenia—Sorafenib—kidney cancer	6.12e-05	0.000626	CcSEcCtD
Etravirine—Malaise—Paclitaxel—kidney cancer	6.09e-05	0.000623	CcSEcCtD
Etravirine—Vertigo—Paclitaxel—kidney cancer	6.07e-05	0.000621	CcSEcCtD
Etravirine—Syncope—Paclitaxel—kidney cancer	6.06e-05	0.00062	CcSEcCtD
Etravirine—Hypersensitivity—Sunitinib—kidney cancer	6.04e-05	0.000618	CcSEcCtD
Etravirine—Decreased appetite—Vincristine—kidney cancer	6.03e-05	0.000617	CcSEcCtD
Etravirine—Vomiting—Erlotinib—kidney cancer	6.03e-05	0.000617	CcSEcCtD
Etravirine—Erythema multiforme—Capecitabine—kidney cancer	6.02e-05	0.000616	CcSEcCtD
Etravirine—Gastrointestinal disorder—Vincristine—kidney cancer	5.99e-05	0.000613	CcSEcCtD
Etravirine—Fatigue—Vincristine—kidney cancer	5.98e-05	0.000612	CcSEcCtD
Etravirine—Rash—Erlotinib—kidney cancer	5.98e-05	0.000611	CcSEcCtD
Etravirine—Dermatitis—Erlotinib—kidney cancer	5.97e-05	0.000611	CcSEcCtD
Etravirine—Insomnia—Gemcitabine—kidney cancer	5.95e-05	0.000609	CcSEcCtD
Etravirine—Eye disorder—Capecitabine—kidney cancer	5.95e-05	0.000609	CcSEcCtD
Etravirine—Headache—Erlotinib—kidney cancer	5.94e-05	0.000607	CcSEcCtD
Etravirine—Loss of consciousness—Paclitaxel—kidney cancer	5.94e-05	0.000607	CcSEcCtD
Etravirine—Constipation—Vincristine—kidney cancer	5.93e-05	0.000607	CcSEcCtD
Etravirine—Pain—Vincristine—kidney cancer	5.93e-05	0.000607	CcSEcCtD
Etravirine—Paraesthesia—Gemcitabine—kidney cancer	5.91e-05	0.000605	CcSEcCtD
Etravirine—Cardiac disorder—Capecitabine—kidney cancer	5.91e-05	0.000605	CcSEcCtD
Etravirine—Asthenia—Sunitinib—kidney cancer	5.89e-05	0.000602	CcSEcCtD
Etravirine—Nausea—Vinblastine—kidney cancer	5.86e-05	0.000599	CcSEcCtD
Etravirine—Somnolence—Gemcitabine—kidney cancer	5.85e-05	0.000599	CcSEcCtD
Etravirine—Convulsion—Paclitaxel—kidney cancer	5.85e-05	0.000599	CcSEcCtD
Etravirine—Nausea—Everolimus—kidney cancer	5.83e-05	0.000597	CcSEcCtD
Etravirine—Diarrhoea—Sorafenib—kidney cancer	5.83e-05	0.000597	CcSEcCtD
Etravirine—Hypertension—Paclitaxel—kidney cancer	5.83e-05	0.000597	CcSEcCtD
Etravirine—Angiopathy—Capecitabine—kidney cancer	5.78e-05	0.000591	CcSEcCtD
Etravirine—Immune system disorder—Capecitabine—kidney cancer	5.75e-05	0.000588	CcSEcCtD
Etravirine—Mediastinal disorder—Capecitabine—kidney cancer	5.74e-05	0.000587	CcSEcCtD
Etravirine—Anxiety—Paclitaxel—kidney cancer	5.73e-05	0.000586	CcSEcCtD
Etravirine—Decreased appetite—Gemcitabine—kidney cancer	5.72e-05	0.000586	CcSEcCtD
Etravirine—Hypersensitivity—Dactinomycin—kidney cancer	5.72e-05	0.000585	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	5.71e-05	0.000584	CcSEcCtD
Etravirine—Gastrointestinal disorder—Gemcitabine—kidney cancer	5.68e-05	0.000581	CcSEcCtD
Etravirine—Discomfort—Paclitaxel—kidney cancer	5.68e-05	0.000581	CcSEcCtD
Etravirine—Fatigue—Gemcitabine—kidney cancer	5.68e-05	0.000581	CcSEcCtD
Etravirine—Gastrointestinal pain—Vincristine—kidney cancer	5.67e-05	0.000581	CcSEcCtD
Etravirine—Dizziness—Sorafenib—kidney cancer	5.64e-05	0.000577	CcSEcCtD
Etravirine—Pain—Gemcitabine—kidney cancer	5.63e-05	0.000576	CcSEcCtD
Etravirine—Constipation—Gemcitabine—kidney cancer	5.63e-05	0.000576	CcSEcCtD
Etravirine—Nausea—Erlotinib—kidney cancer	5.63e-05	0.000576	CcSEcCtD
Etravirine—Dry mouth—Paclitaxel—kidney cancer	5.62e-05	0.000575	CcSEcCtD
Etravirine—Diarrhoea—Sunitinib—kidney cancer	5.61e-05	0.000574	CcSEcCtD
Etravirine—Mental disorder—Capecitabine—kidney cancer	5.58e-05	0.000571	CcSEcCtD
Etravirine—Asthenia—Dactinomycin—kidney cancer	5.57e-05	0.00057	CcSEcCtD
Etravirine—Confusional state—Paclitaxel—kidney cancer	5.56e-05	0.000569	CcSEcCtD
Etravirine—Malnutrition—Capecitabine—kidney cancer	5.54e-05	0.000567	CcSEcCtD
Etravirine—Abdominal pain—Vincristine—kidney cancer	5.49e-05	0.000561	CcSEcCtD
Etravirine—Body temperature increased—Vincristine—kidney cancer	5.49e-05	0.000561	CcSEcCtD
Etravirine—Infection—Paclitaxel—kidney cancer	5.48e-05	0.00056	CcSEcCtD
Etravirine—Flatulence—Capecitabine—kidney cancer	5.46e-05	0.000559	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—kidney cancer	5.44e-05	0.000556	CcSEcCtD
Etravirine—Dizziness—Sunitinib—kidney cancer	5.42e-05	0.000555	CcSEcCtD
Etravirine—Feeling abnormal—Gemcitabine—kidney cancer	5.42e-05	0.000555	CcSEcCtD
Etravirine—Shock—Paclitaxel—kidney cancer	5.42e-05	0.000555	CcSEcCtD
Etravirine—Vomiting—Sorafenib—kidney cancer	5.42e-05	0.000555	CcSEcCtD
Etravirine—Nervous system disorder—Paclitaxel—kidney cancer	5.4e-05	0.000553	CcSEcCtD
Etravirine—Thrombocytopenia—Paclitaxel—kidney cancer	5.4e-05	0.000552	CcSEcCtD
Etravirine—Rash—Sorafenib—kidney cancer	5.38e-05	0.00055	CcSEcCtD
Etravirine—Dermatitis—Sorafenib—kidney cancer	5.37e-05	0.00055	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—kidney cancer	5.36e-05	0.000548	CcSEcCtD
Etravirine—Skin disorder—Paclitaxel—kidney cancer	5.35e-05	0.000548	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	5.34e-05	0.000547	CcSEcCtD
Etravirine—Headache—Sorafenib—kidney cancer	5.34e-05	0.000546	CcSEcCtD
Etravirine—Hyperhidrosis—Paclitaxel—kidney cancer	5.33e-05	0.000545	CcSEcCtD
Etravirine—Diarrhoea—Dactinomycin—kidney cancer	5.31e-05	0.000544	CcSEcCtD
Etravirine—Anorexia—Paclitaxel—kidney cancer	5.25e-05	0.000538	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—kidney cancer	5.25e-05	0.000537	CcSEcCtD
Etravirine—Vision blurred—Capecitabine—kidney cancer	5.22e-05	0.000534	CcSEcCtD
Etravirine—Vomiting—Sunitinib—kidney cancer	5.22e-05	0.000534	CcSEcCtD
Etravirine—Body temperature increased—Gemcitabine—kidney cancer	5.2e-05	0.000532	CcSEcCtD
Etravirine—Tremor—Capecitabine—kidney cancer	5.19e-05	0.000531	CcSEcCtD
Etravirine—Rash—Sunitinib—kidney cancer	5.17e-05	0.000529	CcSEcCtD
Etravirine—Dermatitis—Sunitinib—kidney cancer	5.17e-05	0.000529	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—kidney cancer	5.16e-05	0.000528	CcSEcCtD
Etravirine—Ill-defined disorder—Capecitabine—kidney cancer	5.14e-05	0.000526	CcSEcCtD
Etravirine—Headache—Sunitinib—kidney cancer	5.14e-05	0.000526	CcSEcCtD
Etravirine—Anaemia—Capecitabine—kidney cancer	5.12e-05	0.000524	CcSEcCtD
Etravirine—Hypersensitivity—Vincristine—kidney cancer	5.11e-05	0.000523	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—kidney cancer	5.08e-05	0.000519	CcSEcCtD
Etravirine—Nausea—Sorafenib—kidney cancer	5.06e-05	0.000518	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—kidney cancer	5.03e-05	0.000514	CcSEcCtD
Etravirine—Malaise—Capecitabine—kidney cancer	5e-05	0.000511	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—kidney cancer	4.99e-05	0.000511	CcSEcCtD
Etravirine—Insomnia—Paclitaxel—kidney cancer	4.98e-05	0.00051	CcSEcCtD
Etravirine—Vertigo—Capecitabine—kidney cancer	4.98e-05	0.000509	CcSEcCtD
Etravirine—Asthenia—Vincristine—kidney cancer	4.98e-05	0.000509	CcSEcCtD
Etravirine—Syncope—Capecitabine—kidney cancer	4.97e-05	0.000509	CcSEcCtD
Etravirine—Paraesthesia—Paclitaxel—kidney cancer	4.95e-05	0.000506	CcSEcCtD
Etravirine—Vomiting—Dactinomycin—kidney cancer	4.94e-05	0.000505	CcSEcCtD
Etravirine—Somnolence—Paclitaxel—kidney cancer	4.9e-05	0.000501	CcSEcCtD
Etravirine—Rash—Dactinomycin—kidney cancer	4.9e-05	0.000501	CcSEcCtD
Etravirine—Nausea—Sunitinib—kidney cancer	4.87e-05	0.000499	CcSEcCtD
Etravirine—Loss of consciousness—Capecitabine—kidney cancer	4.87e-05	0.000498	CcSEcCtD
Etravirine—Decreased appetite—Paclitaxel—kidney cancer	4.79e-05	0.00049	CcSEcCtD
Etravirine—Hypertension—Capecitabine—kidney cancer	4.78e-05	0.00049	CcSEcCtD
Etravirine—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.76e-05	0.000487	CcSEcCtD
Etravirine—Fatigue—Paclitaxel—kidney cancer	4.75e-05	0.000486	CcSEcCtD
Etravirine—Diarrhoea—Vincristine—kidney cancer	4.75e-05	0.000486	CcSEcCtD
Etravirine—Asthenia—Gemcitabine—kidney cancer	4.72e-05	0.000483	CcSEcCtD
Etravirine—Constipation—Paclitaxel—kidney cancer	4.71e-05	0.000482	CcSEcCtD
Etravirine—Pain—Paclitaxel—kidney cancer	4.71e-05	0.000482	CcSEcCtD
Etravirine—Anxiety—Capecitabine—kidney cancer	4.7e-05	0.000481	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.69e-05	0.000479	CcSEcCtD
Etravirine—Discomfort—Capecitabine—kidney cancer	4.66e-05	0.000477	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—kidney cancer	4.62e-05	0.000473	CcSEcCtD
Etravirine—Dry mouth—Capecitabine—kidney cancer	4.61e-05	0.000472	CcSEcCtD
Etravirine—Nausea—Dactinomycin—kidney cancer	4.61e-05	0.000472	CcSEcCtD
Etravirine—Dizziness—Vincristine—kidney cancer	4.59e-05	0.00047	CcSEcCtD
Etravirine—Confusional state—Capecitabine—kidney cancer	4.56e-05	0.000467	CcSEcCtD
Etravirine—Feeling abnormal—Paclitaxel—kidney cancer	4.54e-05	0.000465	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.53e-05	0.000464	CcSEcCtD
Etravirine—Gastrointestinal pain—Paclitaxel—kidney cancer	4.51e-05	0.000461	CcSEcCtD
Etravirine—Diarrhoea—Gemcitabine—kidney cancer	4.5e-05	0.000461	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—kidney cancer	4.49e-05	0.00046	CcSEcCtD
Etravirine—Infection—Capecitabine—kidney cancer	4.49e-05	0.00046	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—kidney cancer	4.48e-05	0.000458	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—kidney cancer	4.46e-05	0.000456	CcSEcCtD
Etravirine—Shock—Capecitabine—kidney cancer	4.45e-05	0.000455	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—kidney cancer	4.44e-05	0.000455	CcSEcCtD
Etravirine—Nervous system disorder—Capecitabine—kidney cancer	4.44e-05	0.000454	CcSEcCtD
Etravirine—Thrombocytopenia—Capecitabine—kidney cancer	4.43e-05	0.000453	CcSEcCtD
Etravirine—Vomiting—Vincristine—kidney cancer	4.41e-05	0.000451	CcSEcCtD
Etravirine—Skin disorder—Capecitabine—kidney cancer	4.39e-05	0.00045	CcSEcCtD
Etravirine—Rash—Vincristine—kidney cancer	4.37e-05	0.000448	CcSEcCtD
Etravirine—Hyperhidrosis—Capecitabine—kidney cancer	4.37e-05	0.000447	CcSEcCtD
Etravirine—Dermatitis—Vincristine—kidney cancer	4.37e-05	0.000447	CcSEcCtD
Etravirine—Abdominal pain—Paclitaxel—kidney cancer	4.36e-05	0.000446	CcSEcCtD
Etravirine—Body temperature increased—Paclitaxel—kidney cancer	4.36e-05	0.000446	CcSEcCtD
Etravirine—Headache—Vincristine—kidney cancer	4.35e-05	0.000445	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—kidney cancer	4.32e-05	0.000442	CcSEcCtD
Etravirine—Anorexia—Capecitabine—kidney cancer	4.31e-05	0.000441	CcSEcCtD
Etravirine—Vomiting—Gemcitabine—kidney cancer	4.19e-05	0.000428	CcSEcCtD
Etravirine—Rash—Gemcitabine—kidney cancer	4.15e-05	0.000425	CcSEcCtD
Etravirine—Dermatitis—Gemcitabine—kidney cancer	4.15e-05	0.000424	CcSEcCtD
Etravirine—Headache—Gemcitabine—kidney cancer	4.12e-05	0.000422	CcSEcCtD
Etravirine—Nausea—Vincristine—kidney cancer	4.12e-05	0.000422	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—kidney cancer	4.1e-05	0.00042	CcSEcCtD
Etravirine—Insomnia—Capecitabine—kidney cancer	4.09e-05	0.000419	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—kidney cancer	4.08e-05	0.000418	CcSEcCtD
Etravirine—Paraesthesia—Capecitabine—kidney cancer	4.06e-05	0.000416	CcSEcCtD
Etravirine—Hypersensitivity—Paclitaxel—kidney cancer	4.06e-05	0.000415	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—kidney cancer	4.05e-05	0.000415	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—kidney cancer	4.03e-05	0.000413	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—kidney cancer	4.02e-05	0.000412	CcSEcCtD
Etravirine—Asthenia—Paclitaxel—kidney cancer	3.95e-05	0.000405	CcSEcCtD
Etravirine—Decreased appetite—Capecitabine—kidney cancer	3.93e-05	0.000402	CcSEcCtD
Etravirine—Nausea—Gemcitabine—kidney cancer	3.91e-05	0.0004	CcSEcCtD
Etravirine—Gastrointestinal disorder—Capecitabine—kidney cancer	3.9e-05	0.0004	CcSEcCtD
Etravirine—Fatigue—Capecitabine—kidney cancer	3.9e-05	0.000399	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—kidney cancer	3.88e-05	0.000397	CcSEcCtD
Etravirine—Constipation—Capecitabine—kidney cancer	3.87e-05	0.000396	CcSEcCtD
Etravirine—Pain—Capecitabine—kidney cancer	3.87e-05	0.000396	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—kidney cancer	3.83e-05	0.000392	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—kidney cancer	3.81e-05	0.00039	CcSEcCtD
Etravirine—Diarrhoea—Paclitaxel—kidney cancer	3.77e-05	0.000386	CcSEcCtD
Etravirine—Feeling abnormal—Capecitabine—kidney cancer	3.73e-05	0.000381	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—kidney cancer	3.72e-05	0.000381	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—kidney cancer	3.71e-05	0.000379	CcSEcCtD
Etravirine—Gastrointestinal pain—Capecitabine—kidney cancer	3.7e-05	0.000378	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—kidney cancer	3.7e-05	0.000378	CcSEcCtD
Etravirine—Dizziness—Paclitaxel—kidney cancer	3.64e-05	0.000373	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—kidney cancer	3.59e-05	0.000368	CcSEcCtD
Etravirine—Abdominal pain—Capecitabine—kidney cancer	3.58e-05	0.000366	CcSEcCtD
Etravirine—Body temperature increased—Capecitabine—kidney cancer	3.58e-05	0.000366	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—kidney cancer	3.57e-05	0.000366	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—kidney cancer	3.52e-05	0.00036	CcSEcCtD
Etravirine—Tension—Doxorubicin—kidney cancer	3.51e-05	0.000359	CcSEcCtD
Etravirine—Vomiting—Paclitaxel—kidney cancer	3.5e-05	0.000359	CcSEcCtD
Etravirine—Rash—Paclitaxel—kidney cancer	3.47e-05	0.000356	CcSEcCtD
Etravirine—Dermatitis—Paclitaxel—kidney cancer	3.47e-05	0.000355	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—kidney cancer	3.47e-05	0.000355	CcSEcCtD
Etravirine—Headache—Paclitaxel—kidney cancer	3.45e-05	0.000353	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—kidney cancer	3.37e-05	0.000344	CcSEcCtD
Etravirine—Hypersensitivity—Capecitabine—kidney cancer	3.33e-05	0.000341	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—kidney cancer	3.31e-05	0.000339	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—kidney cancer	3.3e-05	0.000338	CcSEcCtD
Etravirine—Nausea—Paclitaxel—kidney cancer	3.27e-05	0.000335	CcSEcCtD
Etravirine—Asthenia—Capecitabine—kidney cancer	3.24e-05	0.000332	CcSEcCtD
Etravirine—Malaise—Doxorubicin—kidney cancer	3.22e-05	0.00033	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—kidney cancer	3.21e-05	0.000328	CcSEcCtD
Etravirine—Syncope—Doxorubicin—kidney cancer	3.2e-05	0.000328	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—kidney cancer	3.14e-05	0.000321	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—kidney cancer	3.09e-05	0.000317	CcSEcCtD
Etravirine—Diarrhoea—Capecitabine—kidney cancer	3.09e-05	0.000317	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—kidney cancer	3.08e-05	0.000316	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—kidney cancer	3.03e-05	0.00031	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.02e-05	0.000309	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—kidney cancer	3e-05	0.000307	CcSEcCtD
Etravirine—Dizziness—Capecitabine—kidney cancer	2.99e-05	0.000306	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—kidney cancer	2.97e-05	0.000304	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—kidney cancer	2.94e-05	0.000301	CcSEcCtD
Etravirine—Infection—Doxorubicin—kidney cancer	2.9e-05	0.000296	CcSEcCtD
Etravirine—Vomiting—Capecitabine—kidney cancer	2.88e-05	0.000294	CcSEcCtD
Etravirine—Shock—Doxorubicin—kidney cancer	2.87e-05	0.000293	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—kidney cancer	2.86e-05	0.000293	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—kidney cancer	2.85e-05	0.000292	CcSEcCtD
Etravirine—Rash—Capecitabine—kidney cancer	2.85e-05	0.000292	CcSEcCtD
Etravirine—Dermatitis—Capecitabine—kidney cancer	2.85e-05	0.000292	CcSEcCtD
Etravirine—Headache—Capecitabine—kidney cancer	2.83e-05	0.00029	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—kidney cancer	2.83e-05	0.00029	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—kidney cancer	2.82e-05	0.000288	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—kidney cancer	2.78e-05	0.000284	CcSEcCtD
Etravirine—Nausea—Capecitabine—kidney cancer	2.69e-05	0.000275	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—kidney cancer	2.64e-05	0.00027	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—kidney cancer	2.62e-05	0.000268	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—kidney cancer	2.59e-05	0.000265	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—kidney cancer	2.53e-05	0.000259	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.52e-05	0.000258	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—kidney cancer	2.51e-05	0.000257	CcSEcCtD
Etravirine—Pain—Doxorubicin—kidney cancer	2.49e-05	0.000255	CcSEcCtD
Etravirine—Constipation—Doxorubicin—kidney cancer	2.49e-05	0.000255	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—kidney cancer	2.4e-05	0.000246	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—kidney cancer	2.38e-05	0.000244	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—kidney cancer	2.3e-05	0.000236	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—kidney cancer	2.3e-05	0.000236	CcSEcCtD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	2.19e-05	0.0024	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	2.19e-05	0.0024	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—SLC2A1—kidney cancer	2.16e-05	0.00237	CbGpPWpGaD
Etravirine—Hypersensitivity—Doxorubicin—kidney cancer	2.15e-05	0.00022	CcSEcCtD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2.13e-05	0.00234	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.1e-05	0.0023	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.1e-05	0.0023	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	2.09e-05	0.0023	CbGpPWpGaD
Etravirine—Asthenia—Doxorubicin—kidney cancer	2.09e-05	0.000214	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.08e-05	0.00228	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	2.07e-05	0.00227	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	2.05e-05	0.00225	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	2.03e-05	0.00223	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTT1—kidney cancer	2.01e-05	0.0022	CbGpPWpGaD
Etravirine—Diarrhoea—Doxorubicin—kidney cancer	1.99e-05	0.000204	CcSEcCtD
Etravirine—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	1.94e-05	0.00212	CbGpPWpGaD
Etravirine—Dizziness—Doxorubicin—kidney cancer	1.93e-05	0.000197	CcSEcCtD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.91e-05	0.0021	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—PTGS1—kidney cancer	1.88e-05	0.00206	CbGpPWpGaD
Etravirine—Vomiting—Doxorubicin—kidney cancer	1.85e-05	0.00019	CcSEcCtD
Etravirine—Rash—Doxorubicin—kidney cancer	1.84e-05	0.000188	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—kidney cancer	1.84e-05	0.000188	CcSEcCtD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.83e-05	0.00201	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTT1—kidney cancer	1.83e-05	0.00201	CbGpPWpGaD
Etravirine—Headache—Doxorubicin—kidney cancer	1.83e-05	0.000187	CcSEcCtD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	1.82e-05	0.002	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTP1—kidney cancer	1.81e-05	0.00198	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	1.8e-05	0.00198	CbGpPWpGaD
Etravirine—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	1.77e-05	0.00194	CbGpPWpGaD
Etravirine—Nausea—Doxorubicin—kidney cancer	1.73e-05	0.000177	CcSEcCtD
Etravirine—CYP2C9—Biological oxidations—PTGS1—kidney cancer	1.72e-05	0.00188	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ABCB1—kidney cancer	1.71e-05	0.00187	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.7e-05	0.00187	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.69e-05	0.00186	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.67e-05	0.00183	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.66e-05	0.00182	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTM1—kidney cancer	1.66e-05	0.00182	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	1.66e-05	0.00182	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP1A1—kidney cancer	1.57e-05	0.00173	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.55e-05	0.0017	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.51e-05	0.00166	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	1.49e-05	0.00163	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	1.49e-05	0.00163	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	1.39e-05	0.00153	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTP1—kidney cancer	1.39e-05	0.00153	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	1.39e-05	0.00153	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	1.37e-05	0.00151	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.37e-05	0.00151	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.37e-05	0.0015	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.29e-05	0.00142	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTM1—kidney cancer	1.28e-05	0.0014	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTP1—kidney cancer	1.27e-05	0.00139	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.26e-05	0.00138	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	1.26e-05	0.00138	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	1.25e-05	0.00137	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.22e-05	0.00134	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL2—kidney cancer	1.22e-05	0.00133	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	1.21e-05	0.00133	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.21e-05	0.00133	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.21e-05	0.00132	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	1.2e-05	0.00131	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.19e-05	0.00131	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—POMC—kidney cancer	1.17e-05	0.00129	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.17e-05	0.00128	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.17e-05	0.00128	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.17e-05	0.00128	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTM1—kidney cancer	1.17e-05	0.00128	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	1.15e-05	0.00126	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.13e-05	0.00124	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	1.11e-05	0.00121	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	1.09e-05	0.0012	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ACY1—kidney cancer	1.07e-05	0.00117	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ACY1—kidney cancer	1.04e-05	0.00114	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.03e-05	0.00113	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.02e-05	0.00112	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACY1—kidney cancer	9.72e-06	0.00107	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS2—kidney cancer	9.35e-06	0.00103	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	9.09e-06	0.000998	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PDHB—kidney cancer	9.07e-06	0.000995	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—POMC—kidney cancer	9.04e-06	0.000992	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PDHB—kidney cancer	8.85e-06	0.000971	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CCBL1—kidney cancer	8.53e-06	0.000935	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	8.52e-06	0.000935	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	8.37e-06	0.000918	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CCBL1—kidney cancer	8.32e-06	0.000913	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.29e-06	0.00091	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PDHB—kidney cancer	8.27e-06	0.000907	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	8.25e-06	0.000905	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—POMC—kidney cancer	8.24e-06	0.000904	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTEN—kidney cancer	8.16e-06	0.000895	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CCBL1—kidney cancer	7.77e-06	0.000853	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.71e-06	0.000846	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	7.69e-06	0.000844	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	7.59e-06	0.000832	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPAT—kidney cancer	7.39e-06	0.000811	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GLIPR1—kidney cancer	7.39e-06	0.000811	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.3e-06	0.000801	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	7.29e-06	0.0008	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.22e-06	0.000792	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPAT—kidney cancer	7.21e-06	0.000791	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GLIPR1—kidney cancer	7.21e-06	0.000791	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	7.19e-06	0.000789	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.03e-06	0.000771	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APRT—kidney cancer	6.87e-06	0.000754	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—FH—kidney cancer	6.87e-06	0.000754	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GLIPR1—kidney cancer	6.74e-06	0.000739	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPAT—kidney cancer	6.74e-06	0.000739	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.72e-06	0.000737	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APRT—kidney cancer	6.71e-06	0.000736	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—FH—kidney cancer	6.71e-06	0.000736	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	6.69e-06	0.000734	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.65e-06	0.00073	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	6.62e-06	0.000726	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.59e-06	0.000723	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.47e-06	0.00071	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPC3—kidney cancer	6.46e-06	0.000709	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACY1—kidney cancer	6.41e-06	0.000703	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPC3—kidney cancer	6.31e-06	0.000692	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA2—kidney cancer	6.29e-06	0.000689	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—FH—kidney cancer	6.27e-06	0.000687	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APRT—kidney cancer	6.27e-06	0.000687	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.16e-06	0.000675	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA2—kidney cancer	6.13e-06	0.000673	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.13e-06	0.000672	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALAD—kidney cancer	6.13e-06	0.000672	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.12e-06	0.000672	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	5.98e-06	0.000656	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALAD—kidney cancer	5.98e-06	0.000656	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.95e-06	0.000652	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPC3—kidney cancer	5.89e-06	0.000646	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	5.85e-06	0.000641	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	5.84e-06	0.000641	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ST3GAL2—kidney cancer	5.84e-06	0.00064	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	5.83e-06	0.00064	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	5.79e-06	0.000635	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CA—kidney cancer	5.75e-06	0.000631	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA2—kidney cancer	5.73e-06	0.000629	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDH1A1—kidney cancer	5.7e-06	0.000626	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.64e-06	0.000619	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC5A3—kidney cancer	5.6e-06	0.000614	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PGK1—kidney cancer	5.6e-06	0.000614	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALAD—kidney cancer	5.58e-06	0.000613	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LDHB—kidney cancer	5.49e-06	0.000603	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC5A3—kidney cancer	5.47e-06	0.0006	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PGK1—kidney cancer	5.47e-06	0.0006	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PDHB—kidney cancer	5.45e-06	0.000598	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	5.45e-06	0.000598	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—POMC—kidney cancer	5.44e-06	0.000596	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LDHB—kidney cancer	5.36e-06	0.000588	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	5.33e-06	0.000584	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CCBL1—kidney cancer	5.13e-06	0.000562	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PGK1—kidney cancer	5.11e-06	0.00056	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.11e-06	0.00056	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.1e-06	0.000559	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LDHB—kidney cancer	5.01e-06	0.000549	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	4.82e-06	0.000529	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA9—kidney cancer	4.76e-06	0.000522	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.69e-06	0.000514	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.66e-06	0.000511	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA9—kidney cancer	4.65e-06	0.00051	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.59e-06	0.000503	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.45e-06	0.000488	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPAT—kidney cancer	4.45e-06	0.000488	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA9—kidney cancer	4.34e-06	0.000476	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.33e-06	0.000475	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.25e-06	0.000466	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APRT—kidney cancer	4.13e-06	0.000453	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FH—kidney cancer	4.13e-06	0.000453	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CRABP1—kidney cancer	4.05e-06	0.000444	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.98e-06	0.000437	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CRABP1—kidney cancer	3.95e-06	0.000434	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPC3—kidney cancer	3.89e-06	0.000426	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.85e-06	0.000422	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA2—kidney cancer	3.78e-06	0.000415	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ITPR2—kidney cancer	3.77e-06	0.000413	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CRABP1—kidney cancer	3.69e-06	0.000405	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALAD—kidney cancer	3.68e-06	0.000404	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ITPR2—kidney cancer	3.68e-06	0.000403	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.6e-06	0.000394	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.51e-06	0.000385	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.47e-06	0.000381	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—kidney cancer	3.43e-06	0.000377	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ACHE—kidney cancer	3.43e-06	0.000377	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ITPR2—kidney cancer	3.43e-06	0.000377	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.37e-06	0.00037	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PGK1—kidney cancer	3.37e-06	0.00037	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ACHE—kidney cancer	3.35e-06	0.000368	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—kidney cancer	3.35e-06	0.000368	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LDHB—kidney cancer	3.3e-06	0.000362	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SCARB1—kidney cancer	3.25e-06	0.000357	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS1—kidney cancer	3.22e-06	0.000353	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SCARB1—kidney cancer	3.17e-06	0.000348	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.17e-06	0.000347	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PSMD7—kidney cancer	3.16e-06	0.000346	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS1—kidney cancer	3.14e-06	0.000344	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—kidney cancer	3.13e-06	0.000343	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACHE—kidney cancer	3.13e-06	0.000343	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PSMD7—kidney cancer	3.08e-06	0.000338	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BCHE—kidney cancer	2.99e-06	0.000328	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SCARB1—kidney cancer	2.96e-06	0.000325	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.95e-06	0.000324	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS1—kidney cancer	2.93e-06	0.000322	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BCHE—kidney cancer	2.92e-06	0.00032	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC5A5—kidney cancer	2.88e-06	0.000316	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PSMD7—kidney cancer	2.88e-06	0.000316	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA9—kidney cancer	2.86e-06	0.000314	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.85e-06	0.000313	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC2A1—kidney cancer	2.79e-06	0.000306	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.77e-06	0.000304	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BCHE—kidney cancer	2.73e-06	0.000299	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.69e-06	0.000296	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.66e-06	0.000291	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.6e-06	0.000285	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.52e-06	0.000277	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CRABP1—kidney cancer	2.44e-06	0.000267	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.41e-06	0.000265	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—kidney cancer	2.38e-06	0.000261	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—kidney cancer	2.32e-06	0.000255	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ITPR2—kidney cancer	2.26e-06	0.000248	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—kidney cancer	2.25e-06	0.000247	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.2e-06	0.000241	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—kidney cancer	2.19e-06	0.00024	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—kidney cancer	2.17e-06	0.000238	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—kidney cancer	2.13e-06	0.000234	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.07e-06	0.000227	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—kidney cancer	2.06e-06	0.000226	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACHE—kidney cancer	2.06e-06	0.000226	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—kidney cancer	2.05e-06	0.000225	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1A1—kidney cancer	2.02e-06	0.000222	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—kidney cancer	1.99e-06	0.000219	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SCARB1—kidney cancer	1.95e-06	0.000214	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS1—kidney cancer	1.93e-06	0.000212	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PSMD7—kidney cancer	1.9e-06	0.000208	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.89e-06	0.000207	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BCHE—kidney cancer	1.8e-06	0.000197	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.78e-06	0.000195	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.72e-06	0.000188	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.7e-06	0.000187	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.55e-06	0.00017	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—POMC—kidney cancer	1.55e-06	0.00017	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—POMC—kidney cancer	1.51e-06	0.000166	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.43e-06	0.000157	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—POMC—kidney cancer	1.41e-06	0.000155	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.35e-06	0.000149	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.32e-06	0.000144	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.25e-06	0.000137	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—kidney cancer	1.23e-06	0.000135	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—kidney cancer	1.2e-06	0.000132	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.12e-06	0.000123	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—kidney cancer	1.08e-06	0.000118	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—kidney cancer	1.05e-06	0.000115	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—kidney cancer	9.8e-07	0.000108	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—POMC—kidney cancer	9.3e-07	0.000102	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.59e-07	8.32e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—kidney cancer	7.41e-07	8.13e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—kidney cancer	7.4e-07	8.12e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—kidney cancer	6.92e-07	7.59e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—kidney cancer	6.47e-07	7.09e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.56e-07	5e-05	CbGpPWpGaD
